H.R. 1512 · 118th Congress (2023–2025)
Greater Access to Contraceptive Options Act
This bill requires the Food and Drug Administration to prioritize review of supplemental applications for over-the counter, self-administered contraceptives (i.e., contraception that is administered without the intervention of a health care professional).
Show official title
To allow women greater access to a wider range of self-administered contraceptives approved under the Federal Food, Drug, and Cosmetic Act.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 1512’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Nancy Mace (R-SC-1)
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Mar 9, 2023 – Mar 17, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Greater Access to Contraceptive Options Act
Display title, Short title · Introduced in House
To allow women greater access to a wider range of self-administered contraceptives approved under the Federal Food, Drug, and Cosmetic Act.
Official title · Introduced in House